Digital Diagnostics Valuation Estimate
Digital Diagnostics Valuation as of Last Funding Round
Digital Diagnostics Company Overview
Digital Diagnostics, formerly known as Butterfly Network, is a company that has developed a handheld, pocket-sized ultrasound device called the Butterfly iQ. The device uses semiconductor technology to offer high-quality imaging at a fraction of the cost of traditional ultrasound machines. The company has raised significant funding, including a $250 million Series D round in 2021, bringing its total funding to over $350 million. Investors in Digital Diagnostics include the Bill & Melinda Gates Foundation, Fidelity, and Fosun Pharma. The company's Butterfly iQ has been used by healthcare professionals in various settings, including clinical, emergency, and remote care, and has been recognized for its potential to improve healthcare accessibility and affordability.
Digital Diagnostics Valuation History
Digital Diagnostics Stock Price
The stock price of Digital Diagnostics can be calculated by taking the valuation of the company divided by the number of shares outstanding. Because a private company can issue new shares at any time, we do not know the current number of shares outstanding.
For illustrative purposes, however, assuming Digital Diagnostics has issued 250 million shares, at the estimated UpMarket valuation of $265.58 million, each share of Digital Diagnostics stock would be worth $1.06.
Buy Digital Diagnostics Stock
If you would like to buy shares in Digital Diagnostics, please provide your information in the form at the top of this page and click the button titled “I want to buy this stock.”
One of our investor relations team members will contact you to discuss Digital Diagnostics stock availability. Note: inquiries are non-binding and shares may only be purchased by accredited investors that meet all eligibility criteria.
UpMarket has offered many similar companies as Pre-IPO investments, including Airbnb, SpaceX, ByteDance, Plaid, Kraken, Databricks, and others. UpMarket also often has funds available that invest in a portfolio of companies potentially including, Digital Diagnostics as well.
Digital Diagnostics Management
Name | Position |
---|---|
Michael Abramoff | CEO |
Chris Meenan | CTO |
Sarah Tibesar | COO |